Our top stories today: Regeneron seeks FDA emergency clearance for COVID-19 therapy; Pelosi and Mnuchin to talk airline relief; and Sam's Club adding 2,000 workers, more discount days for holiday shopping.Learn more about your ad choices. Visit megaphone.fm/adchoices

Wall Street Breakfast October 8: Regeneron Seeks FDA Emergency Clearance For COVID-19 Therapy

Seeking Alpha's flagship Wall Street Breakfast provides investors an overview of key investment news every morning and afternoon.Transcripts: seekingalpha.com/wsb

Business

Investing

Careers

Management & Marketing

Business News

Shopping

News

Snap sees up to 18% revenue growth in current quarter, stock rockets. (00:24) Alphabet (GOOG) (GOOGL) jumps as YouTube, search drive easy revenue beat. (01:55) Microsoft (MSFT) jumps as Azure continues strong growth, aided by AI. (03:21)Episode transcripts seekingalpha.com/wsb.Show links: Biggest stock movers today: GOOG, MSFT, SNAP, and moreHertz slides 20% as depreciating Teslas dent the bottom lineHonda to spend C$15B to expand electric vehicle efforts in CanadaFCC votes to bring back net neutrality rulesSign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.

Snap soars on surprise profit beat, strong revenue forecast

GDP +1.6%, the slowest pace in 2 years, as inflation came in hot. (0:16) Wall Street rushes to defend Meta stock. (3:33) Biggest oil ETF sees biggest outflows ever. (4:42)Show NotesDavid Einhorn: Gold demand from the East is pushing its price higherOnly 14 S&P; stocks have a 3% yield and have climbed over 10% YTD7 Stocks in Fin-tech and Payments Baird analysts like the mostEpisode transcripts seekingalpha.com/wsbSign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.

Weak GDP raises stagflation debate

Nvidia (NVDA) to buy two Israeli startups aiming to run AI models more cheaply. (00:25) META earnings call: More spending on AI ahead before payoff. (01:14) Microsoft-backed Rubrik (RBRK) prices IPO at $32/shr, above indicated range. (02:32)Episode transcripts seekingalpha.com/wsb.Show links: Biggest stock movers today: META, IBM, F, and moreWalmart, Kroger shares hint at concerns about Amazon's low-cost delivery plan, UBS saysGDP watch: U.S. economic growth likely slowed in Q1BHP weighs potential takeover of Anglo American - Bloomberg (update)Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.

Nvidia to acquire two Israeli AI startups

Boeing topped estimates on the top and bottom lines. (0:16) AT&T; reaffirms guidance. (1:46) Iron ore futures hit highest level in 7 weeks. (3:53) Show NotesStock investors facing 'meaningful losses' but hope lies in key metricDurable goods orders rise more than expected in MarchEpisode transcripts seekingalpha.com/wsbSign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.

Boeing cites safety progress as loss narrows

Google (GOOG) (GOOGL) delays phaseout of third-party cookies in Chrome yet again. (00:26) Tesla (TSLA) rallies after pointing to its upcoming affordable models. (01:10) FTC votes to ban non-compete clauses. (02:08)Episode transcripts seekingalpha.com/wsb.Show links: Biggest stock movers today: TSLA, TXN, ENPH, and moreJPMorgan CEO Jamie Dimon: U.S. economy is booming, but beware of fiscal dominanceGrayscale files to register shares of ethereum trust, plans for lower-fee substituteHistory suggests the materials sector is about to hit a seasonal peak, RenMac saysSign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.

Wall Street Breakfast October 8: Regeneron Seeks FDA Emergency Clearance For COVID-19 Therapy

Download our free app to listen on your phone